HbA1c is Good for the Big Diabetes Picture but CGM is Key for the Data Close-Up
ACP 2025. The timely glucose data available with continuous glucose monitoring is what's needed for optimal daily diabetes control, says Tom Martens, MD.
Pancreatic, Colorectal Cancer Rates Rising in Young Adults, Nationwide Study Warns
The increase in pancreatic cancer among Americans aged 15 to 34 is particularly alarming and should alert clinicians to heed relevant GI symptoms as suspicious.
FDA Approves Dupilumab for Chronic Spontaneous Urticaria Uncontrolled by Antihistamines
Dupilumab (Dupixent) is the first new targeted therapy for CSU in over a decade.
Patient Navigation Program Improves Colonoscopy Completion Rates After Abnormal FIT Results
The phone-based patient navigation intervention addressed barriers to CRC testing follow-up and included patient education.
Emerging Therapies Show Potential for Hard-to-Treat Chronic Spontaneous Urticaria
New data highlight the potential of dupilumab, remibrutinib, and barzolvolimab to expand treatment options for patients with CSU unresponsive to current therapies.
Elinzanetant Reduces Vasomotor Symptoms of Menopause Across BMI, Smoking Status
Pooled data from the OASIS clinical trial program showed consistent efficacy of elinzanetant across BMI and smoking history subgroups, highlighting its broad applicability.
Prediabetes Affects More than 97 Million Americans but 77 Million of Them Are Not Aware
The mildly elevated glycemia of prediabetes is a pathological condition with serious risks for those 77 million, says endocrinologist Samuel Dagogo-Jack, MD, DSc.
Lilly’s Oral GLP-1 Orforglipron Shows Significant and Competitive A1c and Weight Reductions in Phase 3 Trial
The positive topline data from the phase 3 ACHIEVE-1 trial suggest the small molecule GLP-1 mimetic could compete with blockbuster weekly injectables for reducing weight, A1c.
ACIP Expands RSV Vaccine Recommendation to At‑Risk Adults Aged 50–59 Years
The CDC advisory committee also endorsed GSK's pentavalent meningococcal vaccine.
GSK: 3-Year Efficacy Data for Arexvy in Older Adults Published in Lancet Respiratory Medicine
A single dose of the RSVPreF3 demonstrated a cumulative efficacy of 62.9% against RSV-LRTD across 3 seasons in adults aged 60 years and older.
Bringing Behavioral Health Into Primary Care: A Collaborative Care Roadmap
ACP 2025: Matthew Press, MD, shares actionable steps for primary care physicians to adopt a collaborative care model, including how to start small and partner with other practices.
Anaphylaxis Treatment Often Falls Short in Prehospital Care: Daily Dose
Your daily dose of the clinical news you may have missed.
Which CRC Screening Method for Which Patient? Rachel Issaka, MD, MAS, Calls for an Honest Conversation
Issaka, from the Fred Hutch Cancer Center, said insurance coverage, a patient's resources, and social determinants of health all factor in the choice.
10 Drugs Approved for Primary Care: Q1 2025
Review 10 new FDA-approved drugs that may soon find a place in your prescribing routine, including new treatments for UTIs, acute pain, and more.
A Comprehensive Approach to Obesity Treatment: Combining Lifestyle, Medication, and Surgery
ACP 2025: GLP-1 medications are advancing obesity care, but lifestyle changes and bariatric surgery remain key components. Laura Davisson, MD, discusses how to personalize treatment strategies.
FDA Grants First-in-Class Marketing Authorization for Digital Therapeutic in Episodic Migraine Prevention
CT-132 is a 12-week app-based intervention that uses validated behavioral techniques to modulate labile brain circuitry involved in migraine, according to Click Therapeutics.
Emergency Care for Cannabis Use Associated with Increased Risk for Dementia in Adults: Canadian Population Study
Adults with a cannabis-related acute care visit or hospitalization were at 23% and 72% greater risk of a new dementia diagnosis within 5 years, a new study finds.
New Insights Into Treatment Resistant Depression Show Gaps in Care: Daily Dose
9 Common Myths About Cancer Screening and the Facts for Your Patients Who Believe Them
Myths and fears about cancer screening may be keeping some of your patients from important tests. Always ask about misconceptions, and then offer the facts.
Matthew Press, MD: How Penn Medicine’s CoCM Model Helps PCPs Treat Mental Health—and Avoid Burnout
ACP 2025: Dr Press discusses how the Penn Integrated Care model equips primary care physicians to manage mental health conditions more effectively while reducing burnout.
